163 related articles for article (PubMed ID: 2194587)
1. Immunologic characterization of the tumor-specific bcr-abl junction in Philadelphia chromosome-positive acute lymphoblastic leukemia.
van Denderen J; van der Plas D; Meeuwsen T; Zegers N; Boersma W; Grosveld G; van Ewijk W
Blood; 1990 Jul; 76(1):136-41. PubMed ID: 2194587
[TBL] [Abstract][Full Text] [Related]
2. Recognition of the ALL-specific BCR-ABL junction in P190bcr-abl by monoclonal antibody ER-FP1.
van Denderen J; ten Hacken P; Berendes P; Zegers N; Boersma W; Grosveld G; van Ewijk W
Leukemia; 1994 Sep; 8(9):1503-9. PubMed ID: 8090030
[TBL] [Abstract][Full Text] [Related]
3. Antibody recognition of the tumor-specific b3-a2 junction of bcr-abl chimeric proteins in Philadelphia-chromosome-positive leukemias.
van Denderen J; ten Hacken P; Berendes P; Zegers N; Boersma W; Grosveld G; van Ewijk W
Leukemia; 1992 Nov; 6(11):1107-12. PubMed ID: 1434792
[TBL] [Abstract][Full Text] [Related]
4. Antibody recognition of the tumor-specific bcr-abl joining region in chronic myeloid leukemia.
van Denderen J; Hermans A; Meeuwsen T; Troelstra C; Zegers N; Boersma W; Grosveld G; van Ewijk W
J Exp Med; 1989 Jan; 169(1):87-98. PubMed ID: 2462613
[TBL] [Abstract][Full Text] [Related]
5. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.
Wetzler M; Talpaz M; Van Etten RA; Hirsh-Ginsberg C; Beran M; Kurzrock R
J Clin Invest; 1993 Oct; 92(4):1925-39. PubMed ID: 8408645
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H
Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840
[TBL] [Abstract][Full Text] [Related]
7. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
[TBL] [Abstract][Full Text] [Related]
8. Absence of alternative splicing in bcr-abl mRNA in chronic myeloid leukemia cell lines.
Hermans A; Selleri L; Gow J; Grosveld GC
Blood; 1988 Dec; 72(6):2066-9. PubMed ID: 2848601
[TBL] [Abstract][Full Text] [Related]
9. Detection of tumor-specific antigens in Philadelphia chromosome positive leukemias.
van Denderen J; ten Hacken P; Berendes P; van Ewijk W
Leuk Lymphoma; 1993; 11 Suppl 1():29-32. PubMed ID: 7504546
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity in lineage derivation of Philadelphia-positive acute lymphoblastic leukemia expressing p190BCR-ABL or p210BCR-ABL: determination by analysis of individual colonies with the polymerase chain reaction.
Estrov Z; Talpaz M; Kantarjian HM; Zipf TF; McClain KL; Kurzrock R
Cancer Res; 1993 Jul; 53(14):3289-93. PubMed ID: 8324740
[TBL] [Abstract][Full Text] [Related]
11. Chronic myeloid leukemia may be associated with several bcr-abl transcripts including the acute lymphoid leukemia-type 7 kb transcript.
Selleri L; von Lindern M; Hermans A; Meijer D; Torelli G; Grosveld G
Blood; 1990 Mar; 75(5):1146-53. PubMed ID: 2407300
[TBL] [Abstract][Full Text] [Related]
12. The function of BCR/ABL and related proto-oncogenes.
Gotoh A; Broxmeyer HE
Curr Opin Hematol; 1997 Jan; 4(1):3-11. PubMed ID: 9050373
[TBL] [Abstract][Full Text] [Related]
13. Philadelphia chromosome-positive chronic myelogenous leukemia with deleted fusion of BCR and ABL genes.
Ohyashiki K; Ohyashiki JH; Iwabuchi H; Tauchi T; Iwabuchi A; Toyama K
Jpn J Cancer Res; 1990 Jan; 81(1):35-42. PubMed ID: 2157692
[TBL] [Abstract][Full Text] [Related]
14. [The cellular and molecular-biological studies on Philadelphia chromosome-positive acute lymphocytic leukemia].
Kunieda Y
Hokkaido Igaku Zasshi; 1993 May; 68(3):337-49. PubMed ID: 8319933
[TBL] [Abstract][Full Text] [Related]
15. [Genetic diagnosis of chronic myeloid leukemia].
Kato C; Naoe T
Nihon Rinsho; 2001 Dec; 59(12):2336-41. PubMed ID: 11766335
[TBL] [Abstract][Full Text] [Related]
16. Philadelphia chromosome-positive leukaemia: the translocated genes and their gene products.
Allen PB; Morgan GJ; Wiedemann LM
Baillieres Clin Haematol; 1992 Oct; 5(4):897-930. PubMed ID: 1308169
[TBL] [Abstract][Full Text] [Related]
17. New type of Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia.
Saglio G; Guerrasio A; Rosso C; Zaccaria A; Tassinari A; Serra A; Rege-Cambrin G; Mazza U; Gavosto F
Blood; 1990 Nov; 76(9):1819-24. PubMed ID: 2224129
[TBL] [Abstract][Full Text] [Related]
18. p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines.
Okuda K; Golub TR; Gilliland DG; Griffin JD
Oncogene; 1996 Sep; 13(6):1147-52. PubMed ID: 8808688
[TBL] [Abstract][Full Text] [Related]
19. Expression of the ABL-BCR fusion gene in Philadelphia-positive acute lymphoblastic leukemia.
Melo JV; Gordon DE; Tuszynski A; Dhut S; Young BD; Goldman JM
Blood; 1993 May; 81(10):2488-91. PubMed ID: 8490164
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a cell line with variant BCR/ABL breakpoint expressing P180BCR/ABL from late-appearing Philadelphia-positive acute biphenotypic leukemia.
Inokuchi K; Shinohara T; Futaki M; Hanawa H; Tanosaki S; Yamaguchi H; Nomura T; Dan K
Genes Chromosomes Cancer; 1998 Nov; 23(3):227-38. PubMed ID: 9790503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]